PRESS RELEASE published on 05/07/2024 at 15:19, 6 months 15 days ago Inside Information / Other news releases Arkema discloses share buyback transactions undertaken from 29 April to 03 May 2024, in line with regulations. Visit their website for more details Transactions Share Buyback Investor Relations Regulation (EU) No 596/2014 ARKEMA
BRIEF published on 04/30/2024 at 09:10, 6 months 23 days ago BlackRock Reduces Its Stake in ARKEMA Asset Management Stock Market BlackRock Crossing Threshold ARKEMA
BRIEF published on 04/30/2024 at 09:03, 6 months 23 days ago BlackRock exceeds 5% of ARKEMA's capital Investment BlackRock Threshold Crossing ARKEMA Collatéral
Published on 11/22/2024 at 23:55, 9 hours 16 minutes ago Boron One Announces Early Warrant Exercise Incentive Program
Published on 11/22/2024 at 23:30, 9 hours 41 minutes ago Electric Royalties Enters Into Definitive Agreement to Acquire 0.75% Gross Revenue Royalty on Producing Punitaqui Copper Mine in Chile
Published on 11/22/2024 at 23:05, 10 hours 6 minutes ago Nexa Resources Announces Closing Transaction of Pukaqaqa Project Sale to Olympic
Published on 11/22/2024 at 22:30, 10 hours 41 minutes ago Delaforce Energy Corp. Announces Acquisition of Bouchard Well Service Ltd.
Published on 11/22/2024 at 18:14, 14 hours 56 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 11/22/2024 at 17:53, 15 hours 17 minutes ago Funding Circle Plc: POS-Transaction in Own Shares
Published on 11/22/2024 at 16:55, 16 hours 15 minutes ago EQS-Adhoc: Comment on withdrawn non-binding offer
Published on 11/22/2024 at 16:00, 17 hours 11 minutes ago Proposed cancellation of admission to trading
Published on 11/21/2024 at 06:58, 2 days 2 hours ago Net Asset Value per share increases with 9.4% in six months to EUR 55.6 thanks to continued strong growth performance of the portfolio
Published on 11/20/2024 at 19:20, 2 days 13 hours ago Peugeot Invest Board of Directors to evolve following the May 2025 Annual General Meeting
Published on 11/20/2024 at 17:45, 2 days 15 hours ago MEDESIS PHARMA HAS COMPLETED ITS CLINICAL STUDY FOR THE TREATMENT OF ALZHEIMER'S DISEASE WITH NANOLITHIUM
Published on 11/20/2024 at 17:45, 2 days 15 hours ago Disclosure of Share Capital and Voting Rights Outstanding as of October 31, 2024
